Genomics has the ability to transform our understanding of cancer, providing researchers with increasingly complex information on tumour heterogeneity and […]
Monte Rosa Therapeutics is a spin-out formed by Versant Ventures, The Institute of Cancer Research (ICR) and Cancer Research UK […]
In a recent paper, published in Nature, researchers have discovered that blebbing might be a survival strategy in melanoma cells, […]
In a new study published in Nature, researchers investigated the molecular mechanisms behind the epigenetic regulation of the NRG1 enhancer […]
In a new study published in Nature, researchers from the Wellcome Sanger Institute and collaborators investigated how Notch1 mutants colonize […]
Written by Bethany Hoernfeldt, Science Writer Scientists have revealed a novel mechanism in chemoresistance that may inspire unique approaches to […]
Written by Bethany Hoernfeldt, Science Writer Researchers at St. Jude Children’s Hospital have discovered the first causal link between “jumping” […]
A new study has revealed how a key complex that facilitates access to enhancers could be targeted to treat over […]
Researchers have identified how inactive cancer cells are kept dormant, until they are awoken and form fatal cancer metastases. Cancer […]
In the latest episode of the Genetics Society’s ‘Genetics Unzipped’ podcast, sponsored by Thermo Fisher Scientific, Geneticist Dr Kat Arney […]
